Hydrophobic Acrylic Toric IOL Designed to Reduce the Effects of Preoperative Corneal Astigmatism

Exclusion Criteria

• •Subjects who have had previous intraocular or corneal surgery in the study eye.
• •Subjects with any clinically significant ocular pathology which would be expected to reduce potential BCDVA to 20/30 or worse in the study eye during the course of the study.
• •Subjects with any anterior segment pathology in the study eye likely to increase the risk of complications from phacoemulsification cataract surgery.
• •Subjects with associated ocular conditions which could affect the stability of the IOL in the study eye.
• •Subjects with a traumatic cataract in the study eye.
• •Subjects with uncontrolled glaucoma in the study eye.
• •Subjects with clinically significant irregular corneal astigmatism in the study eye, as determined by the medical judgment of the Investigator.
• •Subjects with clinically significant corneal pathology potentially affecting topography of either eye.
• •Subjects with any ocular condition that could prevent the possibility of a visual outcome better than 20/30 in the study eye.
• •Subjects with a difference of greater than 0.50D of corneal astigmatism as measured with the IOL Master and the topographer in the study eye using vector analysis.
• •Subjects with an anterior chamber depth \<2mm in the study eye.
• •Subjects with potential BCDVA of 20/200 or worse in the fellow eye.